Chan, Alexander Auclair, Romany Gao, Qi Ghione, Paola Horwitz, Steven Dogan, Ahmet Roshal, Mikhail Lin, Oscar
Published in
Cytometry. Part B, Clinical cytometry
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon mature T-cell neoplasm occurring in patients with textured breast implants, typically after 7-10 years of exposure. Although cytopathologic or histopathologic assessment is considered the gold standard diagnostic method for BIA-ALCL, flow cytometry (FC)-based immunop...
Altube, Alejandra Chelin, Daniela Gomez, Mariela Malusardi, Cecilia Sciaccaluga, Dolores Cabral, Cecilia Auat, Mariangeles
Published in
Cytometry. Part B, Clinical cytometry
Matos, Daniel Mazza
Published in
Cytometry. Part B, Clinical cytometry
Placek, Alexander Lockhart, Brian Miller, Karin P Wertheim, Gerald B Maude, Shannon L Wood, Brent L Kovach, Alexandra E
Published in
Cytometry. Part B, Clinical cytometry
Ramalingam, Thulasi Raman Vaidhyanathan, Lakshman Muthu, Anurekha Swaminathan, Venkateswaran Vellaichamy Uppuluri, Ramya Raj, Revathi
Published in
Cytometry. Part B, Clinical cytometry
CD19 is frequently targeted for immunotherapy in B cell malignancies, which may result in loss of CD19 expression in leukemic cells as an escape mechanism. Stage 0 hematogones (Hgs) are normal CD19-negative very early B cell precursors that can be potentially mistaken for CD19 negative residual leukemic cells by flow cytometry (FCM) in B cell acute...
Ebo, Didier Beyens, Michiel Toscano, Alessandro Mertens, Christel Elst, Jessy Sabato, Vito
Published in
Cytometry. Part B, Clinical cytometry
Mizuta, Shumpei Iwasaki, Makoto Bandai, Noriko Yoshida, Saya Watanabe, Asami Takashima, Hiroshi Ueshimo, Takeshi Bandai, Kazuhiro Fujiwara, Kensuke Hiranuma, Naoko
...
Published in
Cytometry. Part B, Clinical cytometry
The CD34+ CD38- population in bone marrow includes hematopoietic stem/progenitor cells. Recently, in acute myeloid leukemia, the focus has shifted to flow cytometry analysis targeting CD34+ CD38- leukemic cells due to their effectiveness in minimal/measurable residual disease detection and prognosis prediction. Nevertheless, the immunophenotype and...
Marballi Basavaraju, Deepak Mishra, Shruti Chhabra, Gaurav Chougule, Sudarshan
Published in
Cytometry. Part B, Clinical cytometry
Early T cell precursor-acute lymphoblastic leukemia (ETP-ALL) is a hematolymphoid malignancy where the blasts demonstrate T cell differentiation markers along with stem cell and myeloid antigen expression. The differential diagnosis of ETP-ALL from non-ETP ALL and mixed phenotype acute leukemia is often challenging due to its overlapping immunophen...
Haem Rahimi, Muzhda Conti, Filippo Llitjos, Jean-Francois Fleurie, Aurore Cerro, Valérie Venet, Fabienne Lukaszewicz, Anne-Claire Monneret, Guillaume
Published in
Cytometry. Part B, Clinical cytometry
Freund, Paul Skopnik, Christopher M Metzke, Diana Goerlich, Nina Klocke, Jan Grothgar, Emil Prskalo, Luka Hiepe, Falk Enghard, Philipp
Published in
Cytometry. Part B, Clinical cytometry
Kidney diseases are a major health concern worldwide. Currently there is a large unmet need for novel biomarkers to non-invasively diagnose and monitor kidney diseases. Urinary cells are promising biomarkers and their analysis by flow cytometry has demonstrated its utility in diverse clinical settings. However, up to date this methodology depends o...
